Aureon Biosciences Obtains $3,838,665 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Aureon Biosciences
  • Mailing Address
    28 Wells Avenue Yonkers, NY 10701
  • Company Description
    Aureon Biosciences is a life science company founded in 2002, dedicated to enabling the advancement of predictive and personalized cancer treatment options.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

2 responses to “Aureon Biosciences Obtains $3,838,665 New Funding Round”

  1. jim says:

    Aureon Biosciences just closed shop yesterday (10/04/2011) citing uncontrolled debt and inability to secure bridge loans from VC

  2. Larry says:

    Did Aureon declare bankruptcy or just closed their doors? Am looking for a possible creditor list to be added to.